VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Arcadia Biosciences, Inc. (RKDA) Total Return Calculator with Dividends Reinvested

Arcadia Biosciences, Inc.

Popular:

The total return for Arcadia Biosciences, Inc. (RKDA) stock is -73.35% over the past 12 months. So far it's down 45.58% this year. The 5-year total return is -98.82%, meaning $10,000 invested in RKDA stock 5 years ago would be worth $118 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in RKDA 1 year ago, it would be worth $2,721 today — you'd have lost $7,279.

With Dividends Reinvested$2,721-72.79%

Price Only (No DRIP)$2,721-72.79%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in RKDA

1Y$2,665-$7,335 (-73.3%)-73.3% CAGR

3Y$1,825-$8,175 (-81.7%)-43.3% CAGR

5Y$118-$9,882 (-98.8%)-58.9% CAGR

10Y$8-$9,992 (-99.9%)-50.9% CAGR

15Y$2-$9,998 (-100.0%)-43.3% CAGR

20Y$2-$9,998 (-100.0%)-34.7% CAGR

30Y$2-$9,998 (-100.0%)-24.7% CAGR

Arcadia Biosciences, Inc. did not pay dividends during this period. Total return = price return.

Loading RKDA total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-45.58%	—	-45.58%	—	$5,442
1Y	-73.35%	-73.35%	-73.35%	—	$2,665
3Y	-81.75%	-43.27%	-81.75%	—	$1,825
5Y	-98.82%	-58.85%	-98.82%	—	$118
10Y	-99.92%	-50.91%	-99.92%	—	$8
15Y	-99.98%	-43.32%	-99.98%	—	$2
20Y	-99.98%	-34.68%	-99.98%	—	$2
30Y	-99.98%	-24.72%	-99.98%	—	$2

Risk & Highlights

Best Year+103.44%2024

Worst Year-77.03%2022

Max Drawdown-80.84%2025-10-17 → 2026-04-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-9.16%	-9.16%	—	+0.41%	-9.6pp
2025	-67.49%	-67.49%	—	+16.64%	-84.1pp
2024	+103.44%	+103.44%	—	+24.00%	+79.4pp
2023	-72.05%	-72.05%	—	+24.81%	-96.9pp
2022	-77.03%	-77.03%	—	-19.95%	-57.1pp

RKDA underperformed the S&P 500 by 104.67pp over the past year (-73.35% vs +31.32%).

Loading summary...

RKDA Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
RKDAArcadia Biosciences, Inc.	$2M	-10.0%	-45.6%	-73.3%	—	-81.7%	-98.8%	-99.9%
PGENPrecigen, Inc.	$1.3B	+5.0%	+2.8%	+214.3%	—	+252.0%	-33.7%	-83.0%
OFIXOrthofix Medical Inc.	$489M	+3.6%	-17.9%	+1.1%	—	-34.5%	-72.2%	-71.6%
SEEDOrigin Agritech Limited	$9M	-3.3%	+0.9%	-2.5%	—	-81.2%	-90.9%	-93.2%
CTVACorteva, Inc.	$54.9B	-3.0%	+20.9%	+32.1%	+1.1pp	+45.5%	+75.4%	+195.9%
FMCFMC Corporation	$1.8B	-14.1%	+3.7%	-54.8%	+3.7pp	-81.5%	-78.7%	-26.2%
BIOXBioceres Crop Solutions Corp.	$31M	-13.6%	-64.3%	-88.4%	—	-95.2%	-96.8%	-95.0%
NUVLNuvalent, Inc.	$6.9B	+0.5%	+3.4%	+52.9%	—	+176.1%	+456.1%	+456.1%
AMTXAemetis, Inc.	$221M	+4.2%	+103.8%	+159.2%	—	+42.7%	-80.5%	+12.1%
ADMArcher-Daniels-Midland Company	$37.6B	+6.3%	+33.0%	+65.7%	+4.2pp	+11.3%	+30.6%	+145.6%
BGBunge Global S.A.	$24.5B	-1.9%	+36.8%	+64.9%	+3.6pp	+48.7%	+55.8%	+142.9%

Compare:RKDA vs PGEN RKDA vs OFIX RKDA vs SEED RKDA vs PGEN vs OFIX

About RKDA Dividend Returns

Arcadia Biosciences, Inc. (RKDA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of RKDA over the past year?

Arcadia Biosciences, Inc. (RKDA) delivered a return of -73.35% over the past year. Since RKDA does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in RKDA be worth today?

A $10,000 investment in Arcadia Biosciences, Inc. one year ago would be worth $2,665 today, representing a loss of $7,335.

Q3Does RKDA pay dividends?

Arcadia Biosciences, Inc. (RKDA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For RKDA, the total return equals the price-only return.

Q4Did RKDA beat the S&P 500?

No, Arcadia Biosciences, Inc. (RKDA) underperformed the S&P 500 by 104.67 percentage points over the past year. RKDA delivered a total return of -73.35%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed RKDA by 104.67pp during this period.

Q5What is RKDA's worst drawdown?

Arcadia Biosciences, Inc. (RKDA) experienced a maximum drawdown of -80.84% over the past year, declining from its peak on 2025-10-17 to its trough on 2026-04-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is RKDA's long-term total return over 10, 20, or 30 years?

Here are Arcadia Biosciences, Inc. (RKDA)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.9% (-50.9% CAGR) — $10,000 would have grown to $8. Over 20 years: -100.0% total return (-34.7% CAGR) — $10,000 → $2. Over 30 years: -100.0% total return (-24.7% CAGR) — $10,000 → $2. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was RKDA's best and worst year?

Arcadia Biosciences, Inc.'s best calendar year was 2024 with a total return of 103.4%. Its worst year was 2022 with a total return of -77.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 180.5 percentage points.